Now showing items 1-2 of 2

    • Does generic entry always increase consumer welfare? 

      Grabowski, Henry; Lewis, Tracy; Guha, Rahul; Ivanova, Zoya; Salgado, Maria; Woodhouse, Sally (Food Drug Law J, 2012)
      This article examines how the nature of competition between brands in a therapeutic category changes after generic entry and provide a framework for analyzing the effect of generic entry on consumer welfare that takes into ...
    • Evolving brand-name and generic drug competition may warrant a revision of the Hatch-Waxman Act. 

      Grabowski, Henry G; Kyle, Margaret; Mortimer, Richard; Long, Genia; Kirson, Noam (Health Aff (Millwood), 2011-11)
      The evolution of pharmaceutical competition since Congress passed the Hatch-Waxman Act in 1984 raises questions about whether the act's intended balance of incentives for cost savings and continued innovation has been achieved. ...